Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 2 mar 2023 · ROSEVILLE, Minn., March 2, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its fourth quarter ended...

  2. 17 sty 2023 · ROSEVILLE, Minn. and SAN DIEGO, Jan. 17, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture,...

  3. 17 sty 2023 · New York (N.Y) – January 17, 2023 - Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its gene editing platform to deliver life-saving cell and gene therapies, announced today that Cibus Global LLC, a Delaware limited liability company (“Cibus”), and Calyxt, Inc. (NASDAQ: CLXT) (“Calyxt ...

  4. 19 maj 2023 · On May 18, 2023, Calyxt stockholders approved the reverse stock split and gave Calyxt's board of directors discretionary authority to select a ratio for the split ranging from 1-for-2 to...

  5. View today's Calyxt Inc stock price and latest CLXT news and analysis. Create real-time notifications to follow any changes in the live stock price.

  6. 3 lis 2022 · Nasdaq provides updated worldwide news headlines. Here you can find up-to-the-minute news and analysis of the company that you are researching for potential investment opportunities. Find the...

  7. Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update. Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its first quarter ended March 31, 2023. Yahoo | May 1, 2023.

  1. Ludzie szukają również